MiNK Therapeutics, Inc. (INKT)
Latest INKT Insider Trades
About MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
- NEW YORK, NY
- 15
- 2021
- XNAS
https://www.minktherapeutics.comSEC filings for INKT on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 1,500 | $19K |
| Grant or award | 10 | 13,697 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
INKT Insider Transactions (Form 4)
837 Form 4 filings on record, the earliest from Dec 3, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Barbara Ryan | Grant or award | Common Stock | 1,281 | $13.86 |
Recent INKT Form 8-K Filings
5INKT Insider Trading - FAQ
What is the latest insider trade for INKT?
MiNK Therapeutics, Inc. (INKT) had 6 insider filings in the last 90 days, with the most recent on 2026-06-05. The full record for INKT runs to 37 Form 4 filings, the earliest from 2024-12-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying INKT stock?
No insider purchases of INKT were filed in the last 90 days.
How many insiders are selling INKT stock?
2 insider sales of INKT were filed in the last 90 days, totaling $19K.
Where can I see INKT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks INKT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow INKT insider buys?
Create a free InsiderAlpha account and press Watch on this page to add INKT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Barbara Ryan view on EDGAR
- - John Bradley Holcomb view on EDGAR
- - Barbara Ryan view on EDGAR
- - Brian Corvese view on EDGAR
- - Peter Behner view on EDGAR
- - Ulf Wiinberg view on EDGAR
- - Barbara Ryan view on EDGAR
- - Barbara Ryan view on EDGAR
- - Jennifer Buell view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where INKT's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track INKT insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
